Tech Company Financing Transactions
Cleveland Diagnostics Funding Round
Cleveland Diagnostics secured a $19 million Series D venture capital round on 2/10/2021. Investors included Lyfe Capital, Cleveland Clinic and private investors.
Transaction Overview
Company Name
Announced On
2/10/2021
Transaction Type
Venture Equity
Amount
$19,000,000
Round
Series D
Investors
Lyfe Capital (Lead Investor)
Proceeds Purpose
Funds raised will be used to expand commercialization of IsoPSA--the company's first diagnostic test, designed to enhance early detection of prostate cancer--as well as to expand internal infrastructure and operations to support platform development for other tests, including breast and lung cancer.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
3615 Superior Ave. 4407B
Cleveland, OH 44114
USA
Cleveland, OH 44114
USA
Phone
Website
Email Address
Overview
Cleveland Diagnostics is developing a breakthrough technology to discover a new class of diagnostics tests with high sensitivity and specificity for many cancers -- early on, when cancer is still curable.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Arnon Chait
Chief Medical Officer
Mark Stovsky
Chief Operating Officer
Aimee Kestranek
Chief Scientific Officer
Boris Zaslavsky
VP - Bus. Development
Robert Rochelle
VP - Finance
Michael Halliburton
Browse more venture capital transactions:
Prev: 2/10/2021: Evolve BioSystems venture capital transaction
Next: 2/10/2021: GoodJob venture capital transaction
Share this article
Where The Data Comes From
We record funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs